Jim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy”
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at where Biohaven Ltd.
Biohaven Pharmaceutical Holding Co Ltd. (BHVN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Knoll Capital Management Fred Knoll | 830,879 | $19,974,331 | +10% | 12.99% |
| 2. | Birchview Capital Matthew Strobeck | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $148.04 | 38,000 | $5,625,675.80 | 2,583,658 | 2022-08-19 | Filing | |
| $123.30 | 1,110 | $136,862.00 | 2,550,801 | 2021-11-10 | Filing | |
| $122.75 | 3,890 | $477,480.00 | 2,549,691 | 2021-11-10 | Filing | |
| $76.00 | 13,157 | $999,932.00 | 2,545,801 | 2021-03-17 | Filing | |
| $85.14 | 10,000 | $851,370.00 | 2,532,644 | 2021-03-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $141.50 | 4,200 | $594,300.00 | 4,065 | 2022-05-10 | Filing | |
| $68.97 | 10,000 | $689,700.00 | 323,912 | 2020-06-16 | Filing | |
| $68.58 | 15,508 | $1,063,582.06 | 676,002 | 2020-06-16 | Filing | |
| $68.15 | 13,334 | $908,742.77 | 333,912 | 2020-06-15 | Filing | |
| $67.83 | 2,464 | $167,126.71 | 726,002 | 2020-06-15 | Filing |
Institutional Investors' Holdings
News See All
Jim Cramer’s Thoughts on These 10 Stocks
Discussing how the market initially reacted, Cramer explained that when the panel of federal judges declared the majority of this year’s tariffs to be unlawful, S&P futures surged overnight.
Biohaven Ltd. (BHVN)’s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy
Biohaven Ltd. (NYSE:BHVN) has announced major breakthroughs with its novel precision immunology therapies, BHV-1400 and BHV-1300, at its 2025 R&D Day in New Haven.
11 Stocks That Will Bounce Back According to Analysts
Major US indexes finished in the green on Wednesday, May 7, after a volatile session as investors reacted to updates from the Federal Reserve and new trade developments.
Jim Cramer Recently Talked About These 15 Stocks
On Tuesday, Jim Cramer, host of Mad Money, offered his perspective on the day’s market rally as he delved into the impact of the ongoing dynamic between President Donald Trump and Federal Reserve Chair...
11 Best Guru Stocks to Buy According to Wall Street Analysts
Wall Street seems to be breathing a little easier after the initial panic over President Trump’s tariffs earlier this month, but the rollercoaster is not over just yet.
12 Stocks with Heavy Insider Buying in 2025
Insider trading is often seen as an important indicator of management’s confidence in their company’s future.
Why Biohaven (BHVN) Stock Is Rallying Today
The FDA agreed to review BHVN's application for the approval of its drug candidate, troriluzole, Biohaven announced today. Additionally, the agency decided to grant the drug Priority Review status.
12 Best Weight Loss Stocks to Buy According to Hedge Funds
Most people have at some point sought to include weight loss and physical exercise in their daily life.
5 Jim Cramer Stock Picks this Week
According to Cramer, Nucor Corporation (NYSE:NUE) is a buy for anyone looking to gain exposure to manufacturing and steel.